Mitogen-activated protein kinase phosphatase (MKP)-1 in immunology, physiology, and disease
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Mitogen-activated protein kinases (MAPKs) are key regulators of cellular physiology and immune responses and abnormality in MAPKs is implicated in many diseases. MAPKs are activated by MAPK kinases through phosphorylation of the threonine and tyrosine residues in the conserved Thr-Xaa-Tyr domain, where Xaa represents amino acid residues characteristic of distinct MAPK subfamilies. Since MAPKs play a crucial role in a variety of cellular processes, a delicate regulatory network has evolved to control their activities. Over the past two decades, a group of dual specificity MAPK phosphatases (MKPs) have been identified that deactivate MAPKs. Since MAPKs can enhance MKP activities, MKPs are considered as an important feedback control mechanism that limits the MAPK cascades. This review outlines the role of MKP-1, a prototypical MKP family member, in physiology and disease. We will first discuss the basic biochemistry and regulation of MKP-1. Next, we will present the current consensus on the immunological and physiological functions of MKP-1 in infectious, inflammatory, metabolic, and nervous system diseases as revealed by studies using animal models. We will also discuss the emerging evidence implicating MKP-1 in human disorders. Finally, we will conclude with a discussion of the potential for pharmacomodulation of MKP-1 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases
Johnson, G. L., & Lapadat, R. (2002) · Science · doi:10.1126/science.1072682 · Cited by 4,295
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
MicroRNA-155 is induced during the macrophage inflammatory response
O'Connell, R. M., Taganov, K. D., Boldin, M. P., Cheng, G., & Baltimore, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610731104 · Cited by 1,866 · cited 1×
“Recently, MAPKs have been shown to regulate the expression of several micro RNAs, including miR-21 (Huang et al., 2009), miR-125a (Monk et al., 2010), and miR-155 (O'Connell et al., 2007; Yin et al., 2008).”
BackgroundKamata, H., Honda, S.-I., Maeda, S., Chang, L., Hirata, H., & Karin, M. (2005) · Cell · doi:10.1016/j.cell.2004.12.041 · Cited by 1,792
Whitmarsh, A. J., & Davis, R. J. (1996) · Journal of Molecular Medicine · doi:10.1007/s001090050063 · Cited by 1,543 · cited 5×
“MAPKs can also enhance the activities of numerous transcription factors, including AP-1 (Whitmarsh and Davis, 1996), CREB (Arthur and Cohen, 2000; Arthur et al., 2004; Eliopoulos et al., 2002; Wong et al., 2004), SRF (Posern and Treisman, 2006), and C/EBPβ (Davis, 1993).”
BackgroundInfluentialSun, H., Charles, C. H., Lau, L. F., & Tonks, N. K. (1993) · Cell · doi:10.1016/0092-8674(93)90383-2 · Cited by 1,156 · cited 3×
“The 3CH134 protein or its human homologue exhibited highly specific phosphatase activity towards the ERK MAPK, both in vitro and in cultured cells (Alessi et al., 1993; Charles et al., 1993; Sun et al., 1993; Zheng and Guan, 1993).”
BackgroundA conserved docking motif in MAP kinases common to substrates, activators and regulators
Tanoue, T., Adachi, M., Moriguchi, T., & Nishida, E. (2000) · Nature Cell Biology · doi:10.1038/35000065 · Cited by 816
Mitogen-activated protein kinase cascades and regulation of gene expression
Su, B., & Karin, M. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80131-2 · Cited by 747
Cytokine Stimulation of Energy Expenditure through p38 MAP Kinase Activation of PPARγ Coactivator-1
Puigserver, P., Rhee, J., Lin, J., Wu, Z., Yoon, J. C., Zhang, C.-Y., Krauss, S., Mootha, V. K., Lowell, B. B., & Spiegelman, B. M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00390-2 · Cited by 732 · cited 3×
“This dephosphorylation likely destabilizes PGC-1α, since p38 stabilizes PGC-1α by phosphorylating the protein at Ser265 and Thr298 (Puigserver et al., 2001).”
BackgroundIdentification of a set of genes expressed during the G0/G1 transition of cultured mouse cells.
Lau, L. F., & Nathans, D. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04057.x · Cited by 567 · cited 2×
“The mouse MKP-1 cDNA was initially identified over 20 years ago as an immediate-early gene induced by serum through differential hybridization screening of a BALB/c 3T3 cDNA library (Lau and Nathans, 1985).”
BackgroundTargeting dual-specificity phosphatases: Manipulating MAP kinase signalling and immune responses
Jeffrey, K. L., Camps, M., Rommel, C., & Mackay, C. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2289 · Cited by 533
Eljaschewitsch, E., Witting, A., Mawrin, C., Lee, T., Schmidt, P. M., Wolf, S., Hoertnagl, H., Raine, C. S., Schneider-Stock, R., Nitsch, R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2005.11.027 · Cited by 445 · cited 2×
“Eljaschewitsch et al. have shown that MKP-1 plays an important role in protecting neurons during CNS inflammation (Eljaschewitsch et al., 2006).”
BackgroundA negative regulator of MAP kinase causes depressive behavior
Duric, V., Banasr, M., Licznerski, P., Schmidt, H. D., Stockmeier, C. A., Simen, A. A., Newton, S. S., & Duman, R. S. (2010) · Nature Medicine · doi:10.1038/nm.2219 · Cited by 412 · cited 2×
“At day 35, CUS-exposed rats displayed decreased sucrose preference and increased escape failures in an active avoidance test (Duric et al., 2010).”
BackgroundMAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051794 · Cited by 370 · cited 9×
“hanced cytokine production (Chi et al., 2006; Hammer et al., 2006; Salojin et al., 2006; Zhao et al., 2006) and increased mortality compared to similarly treated wildtype mice.”
BackgroundResultInfluentialHammer, M., Mages, J., Dietrich, H., Servatius, A., Howells, N., Cato, A. C. B., & Lang, R. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051753 · Cited by 327 · cited 7×
“…(Chi et al., 2006; Salojin et al., 2006; Zhao et al., 2006), the chemokines macrophage inflammatory protein (MIP)-1α (CCL3), MIP-1β (CCL4), MCP-1, and CXCL2 (Hammer et al., 2006; Salojin et al., 2006), iNOS (Calvert et al., 2008; Wang et al., 2009) and cyclooxygenase 2 (COX-2) (Lasa et al., 2002).”
BackgroundResultInfluentialBhattacharyya, S., Brown, D. E., Brewer, J. A., Vogt, S. K., & Muglia, L. J. (2007) · Blood · doi:10.1182/blood-2006-10-048215 · Cited by 249 · cited 1×
“Mechanistically, the glucocorticoid receptor (GR) is essential for steroid-mediated MKP-1 induction in macrophages, as glucocorticoidtreated peritoneal macrophages from GR knockout mice lacked significant MKP-1 induction (Bhattacharyya et al., 2007).”
BackgroundZhao, Q., Shepherd, E. G., Manson, M. E., Nelin, L. D., Sorokin, A., & Liu, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411760200 · Cited by 207 · cited 11×
“MKP-1 mediated-inhibition of cytokine production was first documented in murine macrophage cell lines (Chen et al., 2002b; Shepherd et al., 2004; Zhao et al., 2005) using either overexpression or knockdown of MKP-1, and later confirmed in primary macrophages (Zhao et al., 2005).”
BackgroundMethodResultInfluentialUp-regulation of miR-21 by HER2/neu signaling promotes cell invasion
Huang, T.-H., Wu, F., Loeb, G. B., Hsu, R., Heidersbach, A., Brincat, A., Horiuchi, D., Lebbink, R. J., Mo, Y.-Y., Goga, A., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.006676 · Cited by 191 · cited 1×
“Recently, MAPKs have been shown to regulate the expression of several micro RNAs, including miR-21 (Huang et al., 2009), miR-125a (Monk et al., 2010), and miR-155 (O'Connell et al., 2007; Yin et al., 2008).”
BackgroundRoger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184 · cited 4×
“Treatment with recombinant MIF also restores TNF-α and IL-8 production in dexamethasone-treated macrophages (Roger et al., 2005).”
BackgroundInfluentialMicroRNA-101 targets MAPK phosphatase-1 to regulate the activation of MAPKs in macrophages
Zhu, Q.-Y., Liu, Q., Chen, J.-X., Lan, K., & Ge, B.-X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000798 · Cited by 152 · cited 1×
“Moreover, it was recently shown that miR-101 directly targets and suppresses MKP-1 through the 3′ UTR, thereby prolonging p38 and JNK activation (Zhu et al., 2010).”
Background
Cited by
Redox regulation of FoxO transcription factors
Klotz, L.-O., Sánchez-Ramos, C., Prieto-Arroyo, I., Urbánek, P., Steinbrenner, H., & Monsalve, M. (2015) · Redox Biology · doi:10.1016/j.redox.2015.06.019 · Cited by 747
Jin, Q., Li, R., Hu, N., Xin, T., Zhu, P., Hu, S., Ma, S., Zhu, H., Ren, J., & Zhou, H. (2018) · Redox Biology · doi:10.1016/j.redox.2017.11.004 · Cited by 463
Teyssier, J.-R., Chauvet-Gelinier, J.-C., Ragot, S., & Bonin, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049677 · Cited by 73
Steelant, B., Seys, S. F., Boeckxstaens, G., Akdis, C. A., Ceuppens, J. L., & Hellings, P. W. (2017) · Rhinology journal · doi:10.4193/rhin15.376 · Cited by 47
Metadata
- Authors
- Wancket, L. M., Frazier, W. J., & Liu, Y.
- Venue
- Life Sciences
- Publisher
- Elsevier BV
- Published
- 2012-02
- Volume
- 90
- Issue
- 7-8
- Pages
- 237-248
- ISSN
- 0024-3205 (ISSN-L)
- OpenAlex
- W2046138697
- Cited by
- 135
- References
- 21
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.